相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
Yu Wei et al.
BLOOD (2016)
Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study
Guillaume Moulis et al.
AUTOIMMUNITY REVIEWS (2015)
Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012
Marc Michel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Can Immune Thrombocytopenia Be Cured with Medical Therapy?
Adam Cuker et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Matthieu Mahevas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
Soames Boyle et al.
BLOOD (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
Pathophysiology and management of primary immune thrombocytopenia
Hirokazu Kashiwagi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
Mohammad Ali Mashhadi et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Chronic Idiopathic Thrombocytopenic Purpura: Mechanisms of Pathogenesis
Terry Gernsheimer
ONCOLOGIST (2009)
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results
Marta Medeot et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)
Donna M. Boruchov et al.
BLOOD (2007)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Maria Gabriella Mazzucconi et al.
BLOOD (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura
D Provan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
P Brændstrup et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Management of adult idiopathic thrombocytopenic purpura
DB Cines et al.
ANNUAL REVIEW OF MEDICINE (2005)
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
F Borst et al.
ANNALS OF HEMATOLOGY (2004)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura
G Emilia et al.
BLOOD (2002)
分享论文
